Levoleucovorin
Levoleucovorin is a medication that is used to treat or prevent toxic effects of methotrexate, a chemotherapy drug. It is also used in combination with fluorouracil, another chemotherapy drug, to treat colorectal cancer. Levoleucovorin works by providing the body with folinic acid, a form of folic acid that helps cells grow and function normally.
As an exporter based in UAE, you may be interested in supplying levoleucovorin to the world market. Levoleucovorin is a valuable product that can help many patients who are undergoing cancer treatment or who have high levels of methotrexate in their blood. However, before you start exporting levoleucovorin, you need to know some important information about this medication.
What are the benefits of levoleucovorin?
Levoleucovorin has several benefits for patients who need it. Some of them are:
- It can reduce the risk of serious side effects from methotrexate, such as kidney damage, bone marrow suppression, and liver toxicity.
- It can enhance the effectiveness of fluorouracil in treating colorectal cancer by increasing its uptake and retention in tumor cells.
- It can improve the quality of life and survival of patients with colorectal cancer who receive fluorouracil-based chemotherapy.
- It can be administered orally or intravenously, depending on the patient’s preference and condition.
What are the challenges of exporting levoleucovorin?
Exporting levoleucovorin is not without challenges. Some of them are:
- Levoleucovorin is a prescription-only medication that requires a valid medical order from a licensed physician. You need to comply with the regulations and requirements of the countries where you export levoleucovorin to ensure its safe and legal distribution.
- Levoleucovorin is a temperature-sensitive product that needs to be stored and transported under controlled conditions. You need to invest in proper storage facilities and transportation equipment to maintain the quality and stability of levoleucovorin.
- Levoleucovorin is a competitive product that faces strong competition from other suppliers and manufacturers. You need to conduct market research and analysis to identify your target customers, their needs and preferences, and your pricing strategy.
What are the prices of levoleucovorin in different countries?
The prices of levoleucovorin may vary depending on the country, the supplier, the quantity, and the quality. Here is a table that shows some examples of levoleucovorin prices in different countries, based on online sources . Please note that these prices are for reference only and may not reflect the actual market prices.
| Country | Strength | Price |
|---|---|---|
| USA | 50 mg | $98.00 |
| Canada | 50 mg | $76.00 |
| UK | 50 mg | $62.00 |
| Australia | 50 mg | $58.00 |
| India | 50 mg | $12.00 |
What are the top five global brands of levoleucovorin?
There are many brands of levoleucovorin available in the market, but some of them have more recognition and reputation than others. Here are some of the top five global brands of levoleucovorin, based on online sources :
- Fusilev: Fusilev is a brand name of levoleucovorin manufactured by Spectrum Pharmaceuticals, a biotechnology company based in the USA. Fusilev is approved by the FDA for the treatment of patients with metastatic colorectal cancer who receive fluorouracil-based chemotherapy and for the rescue after high-dose methotrexate therapy in patients with osteosarcoma.
- Isovorin: Isovorin is a brand name of levoleucovorin manufactured by Pfizer, a pharmaceutical company based in the USA. Isovorin is approved by the EMA for the treatment of patients with advanced colorectal cancer who receive fluorouracil-based chemotherapy and for the rescue after high-dose methotrexate therapy in patients with osteosarcoma or other malignancies.
- Leucovorin Teva: Leucovorin Teva is a brand name of levoleucovorin manufactured by Teva Pharmaceutical Industries, a pharmaceutical company based in Israel. Leucovorin Teva is approved by the FDA for the treatment of patients with metastatic colorectal cancer who receive fluorouracil-based chemotherapy and for the rescue after high-dose methotrexate therapy in patients with osteosarcoma.
- Levofolene: Levofolene is a brand name of levoleucovorin manufactured by Sanofi, a pharmaceutical company based in France. Levofolene is approved by the EMA for the treatment of patients with advanced colorectal cancer who receive fluorouracil-based chemotherapy and for the rescue after high-dose methotrexate therapy in patients with osteosarcoma or other malignancies.
- Levoleucovorin Accord: Levoleucovorin Accord is a brand name of levoleucovorin manufactured by Accord Healthcare, a pharmaceutical company based in India. Levoleucovorin Accord is approved by the EMA for the treatment of patients with advanced colorectal cancer who receive fluorouracil-based chemotherapy and for the rescue after high-dose methotrexate therapy in patients with osteosarcoma or other malignancies.
Conclusion
Levoleucovorin is a medication that can help many patients who need it. As an exporter based in UAE, you can take advantage of this opportunity and supply levoleucovorin to the world market. However, you need to be aware of the benefits, challenges, prices, and brands of levoleucovorin before you start exporting it. By doing so, you can optimize your business and satisfy your customers.